Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of Alzheimer’s disease.
http://dlvr.it/TNx2TY
 
                
                            Posted in
                        Search Canada Online Listing        
                                Drug to slow early-stage Alzheimer’s disease approved by Health Canada
You May Also Like
More From Author
 
                                            World Series games really can boost heart rates for fans, cardiologists say
 
                                            
 
                                     
  
                                 
                                